Psoriasis child In contrast, current novel therapeutic agents are designed from a better understanding of the immune processes involved in psoriasis and by the specific targeting of molecular mediators. Seborrheic psoriasis
This type of therapy was superseded by ultraviolet therapy. Psoriasis child. Seborrheic psoriasis
It monly causes red scaly patches to appear on the skin. Psoriasis can also cause inflammation of the joints, which is known as psoriatic arthritis. It was during the early part of the 20th century that it was recognised that for psoriasis the therapeutic property of sunlight was due to the wavelengths classified as ultraviolet (UV) light. Antibiotics are not indicated in routine treatment of psoriasis. In the more recent past Fowler's solution, which contains a poisonous and carcinogenic arsenic pound, was used by dermatologists as a treatment for psoriasis during the 18th and 19th centuries. An alternate viewpoint sees the disease as being an immune-mediated disorder in which the excessive reproduction of skin cells is secondary to factors produced by the immune system. While many products today use the phrase in their advertising, it originated in a 1960s advertising campaign for Tegrin, a coal tar-based medicated soap. Psoriasis child. Psoriasis is usually graded as mild (affecting less than 3% of the body), moderate (affecting 3-10% of the body) or severe. Around one-third of people with psoriasis report a family history of the disease, and researchers have identified geic loci associated with the condition. Climatotherapy involves the notion that some diseases can be successfully treated by living in particular climate. Plaques frequently occur on the skin of the elbows and knees, but can affect any area including the scalp and genitals. Many of the most effective agents used to treat severe psoriasis carry an increased risk of significant morbidity including skin cancers, lymphoma and liver disease. It is thought that T cells (which normally help protect the body against infection) bee active, migrate to the dermis and trigger the release of cytokines (tumor necrosis factor-alpha TNFIą, in particular) which cause inflammation and the rapid production of skin cells. |